Related Experiment Video
Updated: Jul 6, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondria-Associated Endoplasmic Reticulum Membranes in Cancer: Hubs for Tumor Progression and Therapeutic
Linlin Yan1, Shaoqing Liu2, Kai Wu3
1Department of Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cell Biology International
|July 4, 2026
Summary
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are crucial for cancer cell adaptation and resistance. Understanding MAM remodeling offers new avenues for targeted cancer therapies and overcoming treatment failure.
Area of Science:
- Cell Biology
- Cancer Biology
- Mitochondrial Research
Background:
- Mitochondria-associated endoplasmic reticulum membranes (MAMs) are key contact sites regulating cellular functions.
- Cancer cells exploit MAMs for metabolic adaptation, stress resistance, and therapeutic resistance.
- Dysfunctional MAMs are increasingly linked to malignant progression.
Purpose of the Study:
- To review the structural and regulatory mechanisms of MAMs.
- To summarize the role of MAMs in cancer progression and therapeutic resistance.
- To discuss emerging therapeutic strategies targeting MAMs.
Main Methods:
- Literature review of structural organization and regulatory mechanisms of MAMs.
- Analysis of evidence linking MAM dysfunction to cancer phenotypes.
- Exploration of therapeutic strategies targeting MAM pathways.
Main Results:
- MAMs' roles in cancer are context-dependent, varying by tumor type and metabolic state.
- MAM remodeling supports cancer adaptation, progression, and resistance.
- Targeting MAMs presents potential therapeutic avenues.
Conclusions:
- MAM plasticity is critical for cancer cell survival and treatment resistance.
- Targeting MAMs and combining therapies may overcome resistance.
- Further understanding of MAM remodeling can guide precision cancer therapy.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...